The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Fluorophenyl-4-(2-Oxo-3-propylimidazolidin-1-yl)benzenesulfonate ID: ALA4097180
PubChem CID: 88909660
Max Phase: Preclinical
Molecular Formula: C18H19FN2O4S
Molecular Weight: 378.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCN1CCN(c2ccc(S(=O)(=O)Oc3cccc(F)c3)cc2)C1=O
Standard InChI: InChI=1S/C18H19FN2O4S/c1-2-10-20-11-12-21(18(20)22)15-6-8-17(9-7-15)26(23,24)25-16-5-3-4-14(19)13-16/h3-9,13H,2,10-12H2,1H3
Standard InChI Key: SZNVNJGEOPBZBC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
8.3700 -6.6902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7827 -7.4001 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.1912 -6.6878 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6641 -7.8169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6629 -8.6365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3710 -9.0454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0806 -8.6360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0778 -7.8133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3692 -7.4081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4954 -7.8025 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2146 -7.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9070 -7.8440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6257 -7.4566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6497 -6.6389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9491 -6.2101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2333 -6.5999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9549 -9.0445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2113 -8.7148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6640 -9.3217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0721 -10.0298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8715 -9.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0411 -7.9156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8514 -9.2356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3705 -9.8964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5579 -9.8103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9698 -5.3932 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 2 1 0
2 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 1 0
18 22 2 0
19 23 1 0
23 24 1 0
24 25 1 0
15 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 378.43Molecular Weight (Monoisotopic): 378.1050AlogP: 3.25#Rotatable Bonds: 6Polar Surface Area: 66.92Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.26CX LogD: 3.26Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -1.76
References 1. Fortin S, Charest-Morin X, Turcotte V, Lauvaux C, Lacroix J, Côté MF, Gobeil S, C-Gaudreault R.. (2017) Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells., 60 (12): [PMID:28535350 ] [10.1021/acs.jmedchem.7b00343 ]